Flortaucipir (18F)

What is Flortaucipir (18F)?[edit | edit source]

Flortaucipir (18F) (TAUVID) is a radioactive diagnostic agent indicated for positron emission tomography (PET) imaging of the brain.

This medicine is indicated for use with positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD).

Flortaucipir F 18 binds to aggregated tau protein.
In the brains of patients with AD, tau aggregates combine to form NFTs, one of two components required for the neuropathological diagnosis of AD.

This medicine cannot be used in patients if:

TAUVID is not indicated for use in the evaluation of patients for chronic traumatic encephalopathy (CTE).

TAUVID is a radioactive drug.
Only authorized persons qualified by training and experience should receive, use, and administer TAUVID.
Handle TAUVID with appropriate safety measures to minimize radiation exposure during administration .
Use waterproof gloves and effective shielding, including syringe shields, when preparing and handling TAUVID.

Recommended Dose

The recommended amount of radioactivity to be administered for PET imaging is 370 MBq (10 mCi), administered as an intravenous bolus injection in a total volume of 10 mL or less.
Initiate imaging approximately 80 minutes after drug administration.

Administration

Assessment of pregnancy status is recommended in females of reproductive potential before administering TAUVID.
Use aseptic technique and radiation shielding during the preparation and administration of TAUVID.
Visually inspect the radiopharmaceutical solution prior to administration. Do not use it if it contains particulate matter or if it is discolored (TAUVID is a clear, colorless solution).
TAUVID may be diluted aseptically with 0.9% Sodium Chloride Injection to a maximum dilution of 1:5 by the end-user. Diluted product should be used within 3 hours of dilution and prior to product expiry.
Assay the dose in a suitable dose calibrator prior to administration.

This medicine is available in fallowing doasage form:

As Injection: 300 MBq/mL to 1,900 MBq/mL (8.1 mCi/mL to 51 mCi/mL) of flortaucipir F 18 injection in a multiple-dose vial.

This medicine is available in fallowing brand namesː

Common possible side effects of this medicine include:

Ensure safe drug handling to protect patients and health care workers from unintentional radiation exposure.
The safety and effectiveness of TAUVID have not been established for patients being evaluated for Chronic Traumatic Encephalopathy.
Consider additional evaluation to confirm the absence of AD pathology in patients with a negative TAUVID scan.

In case of overdose, call the poison control helpline of your country. In the United States, call 1-800-222-1222.

Overdose related information is also available online at poisonhelp.org/help.
In the event that the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services. In the United States, call 911.

TAUVID, have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of radiation dose.
Advise a pregnant woman of the potential risks of fetal exposure to radiation doses with administration of TAUVID.
TAUVID is not likely to be used in females of reproductive age.

The safety and effectiveness of TAUVID in pediatric patients have not been established.

Store TAUVID at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) .
TAUVID does not contain a preservative.
Store TAUVID upright in a shielding container.
The expiration date and time are provided on the container label.
Use TAUVID within the labeled expiration.

Handling

This preparation is approved for use by persons under license by the Nuclear Regulatory Commission or the relevant regulatory authority of an Agreement State.

Flortaucipir (18F) Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.